Limited humoral immunity in hepatitis C virus infection (Q45752127)

15 December 2017

title

Limited humoral immunity in hepatitis C virus infection (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

15 December 2017

author name string

Chen M

1 reference

15 December 2017

Sällberg M

1 reference

15 December 2017

Sönnerborg A

1 reference

15 December 2017

Mattsson L

1 reference

15 December 2017

Jin L

1 reference

15 December 2017

Birkett A

1 reference

15 December 2017

Peterson D

1 reference

15 December 2017

Milich DR

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

15 December 2017

published in

Gastroenterology

1 reference

15 December 2017

volume

116

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

135-143

1 reference

15 December 2017

Hepatitis C viremia in patients with hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Flavivirus genome organization, expression, and replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Genetic organization and diversity of the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Persistence of HCV despite antibodies to both putative envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

The serology of chronic hepatitis B infection revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Colorimetric detection of competitive PCR products for quantification of hepatitis C viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Use of alpha-N,N-bis[carboxymethyl]lysine-modified peroxidase in immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Genetic control of the murine humoral response to distinct epitopes of hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Role of B cells in antigen presentation of the hepatitis B core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Immune responses to the hepatitis C virus NS4A protein are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Turning off follicular dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Hypervariable regions in the putative glycoprotein of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Marked sequence diversity in the putative envelope proteins of hepatitis C viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Diagnosis of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

Immunodominant regions within the hepatitis C virus core and putative matrix proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970237-4

7 January 2021

10.1016/S0016-5085(99)70237-4

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017